La rétine est un tissu spécialisé dans le traitement de l'information visuelle par l'intermédiaire des photorécepteurs, cônes et bâtonnets, et des neurones de deuxième ordre, les cellules bipolaires et les cellules ganglionnaires dont les axones forment le nerf optique. Notre groupe s'intéresse à élucider les mécanismes génétiques impliqués dans les maladies rares stationnaires, comme dans la cécité nocturne congénitale stationnaire (CNCS), ou progressives comme dans la dystrophie de type bâtonnet-cône (DBC). Cette thèse apporte de nombreuses connaissances sur la physiologie rétinienne. D'une part, nous avons identifié GPR179, un nouveau gène impliqué dans la CNCS complète, étudié la localisation de la protéine et la physiopathologie des protéines mutantes. Nous avons également créé et caractérisé fonctionnellement un nouveau modèle souris invalidé pour GPR179 qui nous a permis de mieux approcher la première synapse rétinienne entre les photorécepteurs et les cellules bipolaires adjacentes. D'autre part, nous avons caractérisé le génotype et le phénotype de l'un des modèles les plus utilisés de la DBC, le rat P23H. Nous avons ensuite développé une approche d'édition génomique pour invalider les mutants RHO ayant un effet dominant négatif en testant in vitro, ex vivo et in vivo les meganucleases, TALEN (Transcription Activator-Like Effector Nuclease) puis le système CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR associated protein 9). / The first steps in vision occur in the retina when rod and cone photoreceptors transform light into a biochemical signal, which gets processed by bipolar cells, ganglion cells and finally by the brain. Our group investigates genetic causes and mechanisms involved in inherited stationary and progressive retinal diseases as congenital stationary night blindness (CSNB), and rod-cone dystrophy (RCD), also called retinitis pigmentosa. This thesis gives several insights on the retinal physiology. On one hand, we identified GPR179, a new gene mutated in complete CSNB, studied the localization and the physiopathology of missense and splice-site mutations. We also delivered a new knock-out mouse model which we functionally characterized, and studied GPR179 partners to provide a better understanding of the first visual synapse between photoreceptors and ON-bipolar cells. On the other hand, we genotypically and phenotypically characterized one of the most popular RCD model, the P23H rat model. There is currently no treatment for RCD and different therapeutic strategies are under investigation. We wanted to deliver the basis for a genome editing approach for RHO mutations, acting as a dominant negative effect, which cannot be addressed by current gene replacement strategies. We opened the field by performing in vitro, ex vivo and in vivo genome editing experiments using meganucleases, TALEN (Transcription Activator-Like Effector Nuclease) and finally CRISPR/Cas9 system (clustered regularly interspaced short palindromic repeats/CRISPR associated protein 9) and revealed how challenging the setting of genome editing strategies was.

CRISPR-Cas9 är ett effektivt genredigeringsverktyg som har upptäckts på senare år. Verktyget härstammar från ett adaptivt immunförsvar hos prokaryoter. Tekniken används för att modifiera DNA hos växter, djur och människor på ett enkelt och billigt sätt. CRISPR-Cas9 har visat sig ha stor potential vid bekämpning av olika sjukdomar däribland cancer som idag är ett globalt hälsoproblem. Inom cancerforskningen ses CRISPR-Cas9 som ett lovande verktyg vid cancerterapi och läkemedelsutveckling. I denna studie sammanställer vi aktuella metoder och användningsområden med CRISPR-Cas9 inom cancerforskning. Dessutom undersöker vi hur denna form av genteknik kan lyftas upp och tillämpas i biologiundervisningen. / CRISPR-Cas9 has recently emerged as an effective genome editing tool. The tool derives from an adaptive immune system in prokaryotes. The technology is used for modification of DNA in plants, animals and humans in a simple and inexpensive way. CRISPR-Cas9 has shown great potential in fighting different diseases like cancer which today is a global health issue. It is seen as a promising tool for cancer research when it comes to cancer therapy and drug development. Here we summarize current methods and applications of CRISPR-Cas9 for cancer research. Furthermore, we explore the possibilities of introducing and applying this kind of genetic engineering in biology teaching. / <p>Framläggning, opponering och respondering skedde skriftligt till följd av covid19.</p>

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第22335号 / 医博第4576号 / 新制||医||1041(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 山下 潤, 教授 岩田 想, 教授 木村 剛 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

No description available.

Die Rolle von Connexinen und Gap Junction-vermittelter Kommunikation in pluripotenten Stammzellen sowie der frühen Embryonalentwicklung sind bis heute nicht vollständig aufgeklärt. Mutationen in humanen Connexinen verursachen eine Vielzahl von Krankheiten. Connexin-defiziente iPS Zellen stellen eine gute Basis für die Erforschung der Rolle von Connexinen während der Embryonalentwicklung und bei der Krankheitsentstehung dar. Das Ziel der vorliegenden Arbeit war es, das CRISPR/Cas9-System in pluripotenten Stammzellen erfolgreich anzuwenden und ein Protokoll zur Erstellung verschiedener Cx43-Defektmutanten zu entwerfen. Nach der Etablierung der CRSIPR/Cas9-Methode in HEK293T-Zellen konnte in der vorliegenden Arbeit darüber hinaus erfolgreich eine Cx43-Defizienz in FSiPS-Zellen erzeugt werden. Weiterhin wurden mehrere Cx43-Mutanten geschaffen und initial auf Pluripotenzmarker und ihr Differenzierungspotential untersucht. Diese Arbeit bildet die Basis für weitere Untersuchungen des Cx43 in iPS-Zellklonen und davon abgeleiteten Zelltypen sowie artifiziellen 3D-Gewebekulturen. Darüber hinaus bildet sie die Grundlage für die Bildung weiterer Connexin-Defektmutanten sowie von iPS-Zellen mit krankheitsrelevanten Mutationen. / The roles of connexins and gap junction-mediated communication in pluripotent stem cells and early embryonic development have not been fully elucidated to date. Mutations in human connexins cause a variety of diseases. Connexin-deficient iPS cells provide a good basis for studying the role of connexins during embryonic development and in disease development. The aim of the present work was to successfully apply the CRISPR/Cas9 system in pluripotent stem cells and to design a protocol to generate different Cx43 defective mutants. Furthermore, after establishing the CRSIPR/Cas9 method in HEK293T cells, a Cx43 deficiency in FSiPS cells was successfully generated. Furthermore, several Cx43 mutants were created and initially screened for pluripotency markers and their differentiation potential. This work forms the basis for further studies of Cx43 in iPS cell clones and derived cell types as well as artificial 3D tissue cultures. Furthermore, it forms the basis for the generation of further connexin defect mutants as well as iPS cells with disease-relevant mutations.

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第21688号 / 医博第4494号 / 新制||医||1036(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 河本 宏, 教授 生田 宏一, 教授 江藤 浩之 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

PART I: CRYSTAL STRUCTURE OF A DIMERIZATIO DOMAIN OF DROSOPHILA CAPRIN Drosophila Melanogaster Caprin (dCaprin) shares conversed HR1 domain with Caprin protein family members, which are RNA binding proteins that play critical roles in many important biological processes, such as synaptic plasticity, stress response, innate immune response and cellular proliferation. One of the Caprin protein family members, Caprin-1, is involved in the pathway of several human diseases, including breast cancer, neurodegenerative disorders, osteosarcoma, hearing loss, and viral infection. The functions of Caprin protein relies on their molecular interactions. Several direct interactions have been established between Caprin-1 and the Fragile X mental retardation protein (FMRP), Ras-GAP SH3 domain-binding protein 1 (G3BP1), and the Japanese encephalitis virus (JEV) core protein. We have determined the crystal structures of a fragment (residues 187-309) of Drosophila Melanogaster Caprin (dCaprin), which mediates homodimerization through a substantial interface created by a mainly alpha-helical fold. A larger hollow surface is created by homodimerization suggesting a protein binding groove. The FMRP binding should not affect dCaprin homodimerization for an integral alpha-helix in the dimeric dCaprein which formed by the FMRP interacting sequence motif. PART II: CHARACTERIZATION OF TWO TYPE VI-B CRESPR SYSTEMS: PGI5CAS1B AND PGI8CAS13B WHICH EFFECTOR PROTEINS ARE CAPABLE OF PROCESSING PRE-CRRNA INTO MATURE CRRNA CRISPR-Cas adaptive immune system protects microorganism from foreign nucleic acids invasion through endonucleases activity guided by RNA, which system has turned to a powerful genome editing tool applied to a multifold species, ranging from bacteria to human. Pgi5Cas13b and Pgi8Cas13b are identified by a computational sequence database mining approach, the CRISPR arrays lack of Cas1 and Cas2 encoding genes but contain a large candidate effector protein around 1,200 amino acids. They can be potentially classified as subtype VI-B CRISPR-Cas systems. We characterized the mature crRNA for Pgi5Cas13b and Pgi8Cas13b via Northern blot and small RNA sequencing. By EMSA (Electrophoretic mobility shift assay) experiments, we identified the binding constant between Pgi5Cas1b/Pgi8Cas13b and their corresponding crRNAs. The CRISPR loci of two of the Cas13b systems were cloned in pACYC vector and expressed in E. coli cells. Small RNAs were extracted and characterized by Northern Blotting and NGS (small RNA-seq) methods. The NGS results revealed the exact sequences of the crRNAs, which show a few new features not previously observed in other systems, including the longest spacer-derived sequences (32 and 31 nt), spacer-derived sequences flanking both ends of the full DR-derived sequence. The results also indicate different rules of pre-crRNA processing by the Pgi5Cas13b and Pgi8Cas13b systems. The characterization of these CRISPR systems extends the application of CRISPR based genome editing tools and promotes the development of single transcript manipulation tools.

No description available.

Genome editing is an exciting field that allows for the precise modification of an organism's DNA. One of the most advanced tools in this area is CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein 9), which creates a DSB (Double-strand break) at a specific location in the genome. This break can then be repaired by the cell using one of two pathways – NHEJ (nonhomologous end joining) or HDR (homology-directed repair) HDR leads to more precise repair and is used to create KI (Knock-In) modifications by introducing a homologous piece of DNA with the desired changes. However, HDR is a rare event that competes with the error prone NHEJ pathway, limiting its efficiency. HDR mainly occurs in the G2 and S phases of the cell cycle, making it a challenge to control and target. To improve KI efficiency, researchers have used strategies such as inhibiting NHEJ or activating HDR. This study focuses on identifying direct and indirect activators of HDR through a library assay screening. We established a robust method for screening compounds in HEK293 cells that relies on a plasmid-based delivery Cas9, gRNA (guide RNA), and synthetic ssDNA (single strand DNA). Out of 3,000 compounds screened, 1% showed a higher signal than the positive control, and approximately 10% presented a higher signal than untreated cells. The top 5 compounds were further validated in dose response. Our system opens new avenues for improving the efficiency of KI modifications.

京都大学 / 0048 / 新制・課程博士 / 博士(農学) / 甲第21827号 / 農博第2340号 / 新制||農||1067(附属図書館) / 学位論文||H31||N5199(農学部図書室) / 京都大学大学院農学研究科応用生物科学専攻 / (主査)教授 佐藤 健司, 准教授 豊原 治彦, 准教授 田川 正朋 / 学位規則第4条第1項該当 / Doctor of Agricultural Science / Kyoto University / DFAM